116 related articles for article (PubMed ID: 10588936)
1. Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1999 Dec; 128(8):1795-803. PubMed ID: 10588936
[TBL] [Abstract][Full Text] [Related]
2. The contribution of nitric oxide to cardiovascular status and responses to vasodilators in conscious, hypertensive, transgenic ((mRen-2)27) rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1998 May; 124(2):299-306. PubMed ID: 9641546
[TBL] [Abstract][Full Text] [Related]
3. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
4. Enhanced involvement of endothelin in the haemodynamic sequelae of endotoxaemia in conscious, hypertensive, transgenic ((mRen-2)27) rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1998 Apr; 123(7):1403-8. PubMed ID: 9579736
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
[TBL] [Abstract][Full Text] [Related]
7. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
8. [Role of nitric oxide in the modulation of the vascular response to angiotensin II in hypertensive rats].
Sánchez Mendoza A; Vázquez Cruz B; Escalante Acosta BA
Arch Inst Cardiol Mex; 1996; 66(4):306-12. PubMed ID: 8984951
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
10. The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase.
O'Sullivan SE; Randall MD; Gardiner SM
J Pharmacol Exp Ther; 2007 May; 321(2):663-72. PubMed ID: 17284670
[TBL] [Abstract][Full Text] [Related]
11. Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2004 Oct; 143(3):422-30. PubMed ID: 15339862
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
[TBL] [Abstract][Full Text] [Related]
13. Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1.
Ballew JR; Watts SW; Fink GD
J Pharmacol Exp Ther; 2001 Feb; 296(2):345-50. PubMed ID: 11160616
[TBL] [Abstract][Full Text] [Related]
14. Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats.
Brosnihan KB; Li P; Figueroa JP; Ganten D; Ferrario CM
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1995-2001. PubMed ID: 18344376
[TBL] [Abstract][Full Text] [Related]
15. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
Yang Y; Macdonald GJ; Duggan KA
Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119
[TBL] [Abstract][Full Text] [Related]
16. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
17. Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats.
Wakefield ID; March JE; Kemp PA; Valentin JP; Bennett T; Gardiner SM
Br J Pharmacol; 2003 Jul; 139(6):1235-43. PubMed ID: 12871844
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
19. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
20. Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats.
Mustafa MR; Dharmani M; Kunheen NK; Sim MK
Regul Pept; 2004 Aug; 120(1-3):15-22. PubMed ID: 15177916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
